Xencor | XNCR - Assets

Stock Price
12.73
Daily Change
-0.08 -0.62%
Monthly
7.25%
Yearly
52.09%
Q2 Forecast
12.42

Xencor reported $875.5M in Assets for its fiscal quarter ending in December of 2025.





Assets Change Date
AbbVie USD 133.96B 62M Dec/2025
Alnylam Pharmaceuticals USD 4.97B 114.67M Dec/2025
Amgen USD 90.59B 445M Dec/2025
Arrowhead Research USD 1.6B 218.89M Dec/2025
AstraZeneca USD 114.07B 382M Dec/2025
Biogen USD 29.44B 232M Dec/2025
Bristol-Myers Squibb USD 96.89B 2.21B Sep/2025
Cytokinetics USD 1.42B 12.02M Dec/2025
GlaxoSmithKline GBP 61.12B 221M Dec/2025
J&J USD 199.21B 6.39B Dec/2025
Karyopharm Therapeutics USD 108.42M 12.18M Dec/2025
MacroGenics USD 256.85M 13.92M Dec/2025
Merck USD 129.55B 12.02B Sep/2025
Novartis USD 110.95B 3.66B Dec/2025
Pfizer USD 208.73B 2.64B Sep/2025
Regeneron Pharmaceuticals USD 40.56B 389.3M Dec/2025
Roche Holding CHF 100.7B 5.94B Dec/2025
Xencor USD 875.5M 6.68M Dec/2025